Meaghan Stolk

651 total citations
20 papers, 518 citations indexed

About

Meaghan Stolk is a scholar working on Genetics, Surgery and Oncology. According to data from OpenAlex, Meaghan Stolk has authored 20 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 10 papers in Surgery and 7 papers in Oncology. Recurrent topics in Meaghan Stolk's work include Mesenchymal stem cell research (11 papers), Tissue Engineering and Regenerative Medicine (7 papers) and Amino Acid Enzymes and Metabolism (3 papers). Meaghan Stolk is often cited by papers focused on Mesenchymal stem cell research (11 papers), Tissue Engineering and Regenerative Medicine (7 papers) and Amino Acid Enzymes and Metabolism (3 papers). Meaghan Stolk collaborates with scholars based in Germany, Austria and Canada. Meaghan Stolk's co-authors include Martina Seifert, Hans‐Dieter Volk, James R. Hammond, Katharina Schallmoser, Dirk Strunk, Dietrich Polenz, Susann Minkwitz, Britt Wildemann, Jochen Ringe and Franka Klatte‐Schulz and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Meaghan Stolk

20 papers receiving 508 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meaghan Stolk Germany 14 233 229 147 59 54 20 518
Junlong Dang China 14 68 0.3× 184 0.8× 201 1.4× 19 0.3× 39 0.7× 20 515
Anja U. Engela Netherlands 8 158 0.7× 349 1.5× 94 0.6× 11 0.2× 4 0.1× 10 454
Mathiyazhagan Rengasamy India 6 142 0.6× 273 1.2× 170 1.2× 18 0.3× 6 0.1× 6 520
Cristina Moreno Spain 15 272 1.2× 291 1.3× 329 2.2× 4 0.1× 35 0.6× 29 841
Sarah E. B. Taylor United States 9 49 0.2× 55 0.2× 216 1.5× 34 0.6× 85 1.6× 9 438
Zheng Zhou China 12 64 0.3× 129 0.6× 283 1.9× 13 0.2× 11 0.2× 48 611
Bart Vaes Netherlands 11 113 0.5× 161 0.7× 225 1.5× 53 0.9× 2 0.0× 17 493
Hye Yun Jeong South Korea 4 123 0.5× 224 1.0× 133 0.9× 21 0.4× 3 0.1× 7 443
Hyoju Yi South Korea 14 60 0.3× 82 0.4× 313 2.1× 39 0.7× 8 0.1× 19 641
Giancarlo Discepoli Italy 11 148 0.6× 226 1.0× 190 1.3× 7 0.1× 5 0.1× 21 614

Countries citing papers authored by Meaghan Stolk

Since Specialization
Citations

This map shows the geographic impact of Meaghan Stolk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meaghan Stolk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meaghan Stolk more than expected).

Fields of papers citing papers by Meaghan Stolk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meaghan Stolk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meaghan Stolk. The network helps show where Meaghan Stolk may publish in the future.

Co-authorship network of co-authors of Meaghan Stolk

This figure shows the co-authorship network connecting the top 25 collaborators of Meaghan Stolk. A scholar is included among the top collaborators of Meaghan Stolk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meaghan Stolk. Meaghan Stolk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stolk, Meaghan, et al.. (2021). Therapies with CCL25 require controlled release via microparticles to avoid strong inflammatory reactions. Journal of Nanobiotechnology. 19(1). 83–83. 8 indexed citations
2.
Stolk, Meaghan, et al.. (2019). Enhanced Immunomodulation in Inflammatory Environments Favors Human Cardiac Mesenchymal Stromal-Like Cells for Allogeneic Cell Therapies. Frontiers in Immunology. 10. 1716–1716. 6 indexed citations
3.
Stolk, Meaghan, et al.. (2017). New insights into tenocyte-immune cell interplay in an in vitro model of inflammation. Scientific Reports. 7(1). 9801–9801. 63 indexed citations
4.
Schneider, Maria, et al.. (2017). Effects on human heart valve immunogenicity in vitro by high concentration cryoprotectant treatment. Journal of Tissue Engineering and Regenerative Medicine. 12(2). e1046–e1055. 8 indexed citations
5.
Stolk, Meaghan, et al.. (2017). Stromal Cells Act as Guardians for Endothelial Progenitors by Reducing Their Immunogenicity After Co-Transplantation. Stem Cells. 35(5). 1233–1245. 25 indexed citations
6.
Stolk, Meaghan & Martina Seifert. (2015). Protein contaminations impact quantification and functional analysis of extracellular vesicle preparations from mesenchymal stromal cells. SHILAP Revista de lepidopterología. 11(2). 44–47. 12 indexed citations
7.
Stich, Stefan, Meaghan Stolk, Claudius Thomé, et al.. (2015). Regenerative and Immunogenic Characteristics of Cultured Nucleus Pulposus Cells from Human Cervical Intervertebral Discs. PLoS ONE. 10(5). e0126954–e0126954. 24 indexed citations
8.
Seifert, Martina, et al.. (2014). Xeno-immunogenicity of ice-free cryopreserved porcine leaflets. Journal of Surgical Research. 193(2). 933–941. 11 indexed citations
9.
Koch, Martina, A. Lehnhardt, Xianwen Hu, et al.. (2013). Isogeneic MSC application in a rat model of acute renal allograft rejection modulates immune response but does not prolong allograft survival. Transplant Immunology. 29(1-4). 43–50. 24 indexed citations
10.
Seifert, Martina, Meaghan Stolk, Dietrich Polenz, & Hans‐Dieter Volk. (2012). Detrimental effects of rat mesenchymal stromal cell pre-treatment in a model of acute kidney rejection. Frontiers in Immunology. 3. 202–202. 46 indexed citations
11.
Seifert, Martina, Gabriela Korus, Uwe Marx, et al.. (2012). Crosstalk between immune cells and mesenchymal stromal cells in a 3D bioreactor system. The International Journal of Artificial Organs. 35(11). 986–995. 16 indexed citations
12.
Stolk, Meaghan, Jochen Ringe, Sophie Van Linthout, et al.. (2012). Immune attributes of cardiac-derived adherent proliferating (CAP) cells in cardiac therapy. Journal of Tissue Engineering and Regenerative Medicine. 7(5). 362–370. 14 indexed citations
13.
Stolk, Meaghan, et al.. (2012). Ischemia–reperfusion injury. Current Opinion in Organ Transplantation. 18(1). 34–43. 69 indexed citations
14.
Seifert, Martina, Gabriela Korus, Uwe Marx, et al.. (2012). Crosstalk between Immune Cells and Mesenchymal Stromal Cells in a 3D Bioreactor System. The International Journal of Artificial Organs. 35(11). 986–995. 13 indexed citations
15.
Schallmoser, Katharina, et al.. (2011). Immunomodulative Efficacy of Bone Marrow-Derived Mesenchymal Stem Cells Cultured in Human Platelet Lysate. Journal of Clinical Immunology. 31(6). 1143–1156. 53 indexed citations
16.
Hara, Yoshiaki, Meaghan Stolk, Jochen Ringe, et al.. (2011). In vivo effect of bone marrow-derived mesenchymal stem cells in a rat kidney transplantation model with prolonged cold ischemia. Transplant International. 24(11). 1112–1123. 48 indexed citations
17.
Robillard, Kevin R., et al.. (2007). Differential regulation of mouse equilibrative nucleoside transporter 1 (mENT1) splice variants by protein kinase CK2. Molecular Membrane Biology. 24(4). 294–303. 23 indexed citations
18.
Stolk, Meaghan, et al.. (2006). IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. Journal of Leukocyte Biology. 80(3). 651–658. 14 indexed citations
19.
Stolk, Meaghan, Elizabeth Cooper, Greg Vilk, David W. Litchfield, & James R. Hammond. (2005). Subtype-specific regulation of equilibrative nucleoside transporters by protein kinase CK2. Biochemical Journal. 386(2). 281–289. 25 indexed citations
20.
Hammond, James R., et al.. (2004). Pharmacological analysis and molecular cloning of the canine equilibrative nucleoside transporter 1. European Journal of Pharmacology. 491(1). 9–19. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Junlong Dang Breakdown of academic impact, for papers by Anja U. Engela Breakdown of academic impact, for papers by Mathiyazhagan Rengasamy Breakdown of academic impact, for papers by Cristina Moreno Breakdown of academic impact, for papers by Sarah E. B. Taylor Breakdown of academic impact, for papers by Zheng Zhou Breakdown of academic impact, for papers by Bart Vaes Breakdown of academic impact, for papers by Hye Yun Jeong Breakdown of academic impact, for papers by Hyoju Yi Breakdown of academic impact, for papers by Giancarlo Discepoli
Rankless by CCL
2026